全文获取类型
收费全文 | 3268篇 |
免费 | 164篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 62篇 |
妇产科学 | 18篇 |
基础医学 | 417篇 |
口腔科学 | 74篇 |
临床医学 | 173篇 |
内科学 | 762篇 |
皮肤病学 | 55篇 |
神经病学 | 236篇 |
特种医学 | 121篇 |
外科学 | 582篇 |
综合类 | 9篇 |
一般理论 | 1篇 |
预防医学 | 141篇 |
眼科学 | 46篇 |
药学 | 211篇 |
中国医学 | 12篇 |
肿瘤学 | 517篇 |
出版年
2023年 | 21篇 |
2022年 | 44篇 |
2021年 | 82篇 |
2020年 | 45篇 |
2019年 | 50篇 |
2018年 | 88篇 |
2017年 | 60篇 |
2016年 | 85篇 |
2015年 | 70篇 |
2014年 | 98篇 |
2013年 | 113篇 |
2012年 | 184篇 |
2011年 | 201篇 |
2010年 | 130篇 |
2009年 | 95篇 |
2008年 | 162篇 |
2007年 | 179篇 |
2006年 | 161篇 |
2005年 | 127篇 |
2004年 | 142篇 |
2003年 | 137篇 |
2002年 | 137篇 |
2001年 | 104篇 |
2000年 | 94篇 |
1999年 | 82篇 |
1998年 | 41篇 |
1997年 | 23篇 |
1996年 | 22篇 |
1995年 | 20篇 |
1994年 | 19篇 |
1993年 | 18篇 |
1992年 | 56篇 |
1991年 | 61篇 |
1990年 | 58篇 |
1989年 | 54篇 |
1988年 | 37篇 |
1987年 | 46篇 |
1986年 | 42篇 |
1985年 | 28篇 |
1984年 | 34篇 |
1983年 | 26篇 |
1982年 | 13篇 |
1979年 | 19篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1973年 | 10篇 |
1970年 | 9篇 |
1967年 | 12篇 |
1966年 | 11篇 |
排序方式: 共有3445条查询结果,搜索用时 31 毫秒
1.
2.
3.
Neoplastic angioendotheliosis has rarely been described as a respiratory disease. A patient is described with pulmonary vascular involvement induced by neoplastic angioendotheliosis in pulmonary vessels. 相似文献
4.
5.
ASTROCYTE-CONDITIONED MEDIUM INDUCES BLOOD-BRAIN BARRIER PROPERTIES IN ENDOTHELIAL CELLS 总被引:6,自引:0,他引:6
6.
Weimin Hu Kentaro Ninomiya Hiroko Ishibashi Naho Maruyama Haruyuki Oshima Hideyo Yamaguchi Shigeru Abe 《Medical mycology》2007,45(2):143-148
We established a novel murine model of pharyngeal candidiasis maintaining stable yeast population and local symptoms characteristic of pharyngeal thrush. The persistent Candida-infection was prolonged by inhalation of beclomethasone dipropionate corticosteroid. The severity of infection lesions was evaluated by determining viable cell number of Candia albicans and scores representing symptomatic curd-like white patch on pharyngeal tissue. The utility of this model was shown by the disappearance of lesions and fungal cells after treatment with fluconazole (FLCZ). The model would be useful for evaluating new chemotherapeutic or immunotherapeutic approaches against pharyngeal candidiasis, as well as in pathological studies. 相似文献
7.
8.
Satsuki Sumitani Shu-Ichi Ueno Yasuhito Ishimoto Takahide Taniguchi Masahito Tomotake Ikuyo Motoki Ken Yamauchi Tetsuro Ohmori 《Seishin shinkeigaku zasshi》2006,108(12):1282-1292
BACKGROUND: Although selective serotonin reuptake inhibitors (SSRIs) are the mainstay of pharmacological treatment for obsessive-compulsive disorder (OCD), some OCD patients do not show improvement. Sometimes, the addition of a low-dose atypical antipsychotic, such as risperidone, or olanzapine, to ongoing SSRI treatment has been shown to be effective. However, there are patients who still show no response after trials with this augmentation therapy. In the present study, we examined the clinical features of OCD patients who showed different responses to pharmacological treatment. SUBJECTS AND METHOD: Fifty OCD patients were divided into three groups according to their pharmacological responses: responders to SSRI (group A: n= 25), responders to SSRI with an atypical antipsychotic (group B: n= 15), and non-responders to both SSRI and SSRI with an atypical antipsychotic (group C: n= 10). We examined the clinical features such as age, sex, age of onset, duration of illness, types of obsessive-compulsive symptoms, severity, improvement after treatment, insight into disease, depression, comorbidity, involving family members in compulsive or ritualistic behavior, and the level of social adaptation of each OCD group. RESULTS: Twenty five patients showed a good response to SSRI monotherapy, 15 showed a response to antipsychotic augmentation, and 10 were non-responders to both SSRI and SSRI with an atypical antipsychotic. Significantly lower insight levels were observed only in group B and higher depressive levels in group C. OCD patients who were refractory to SSRI monotherapy showed comorbidity at a significantly higher frequency. OCD patients in group A showed significantly greater improvement, and group B showed inferior social adaptation after treatment. There were no significant differences in age, sex, age of onset, duration of illness, severity, involving family members in compulsive or ritualistic behavior, and social adaptation before treatment in the three OCD groups. CONCLUSION: There were differences in the clinical features of OCD patients who showed different responses to pharmacological treatment. Our results suggest that OCD is clinically and biologically heterogeneous. It may be important to divide OCD patients into subgroups for future studies. 相似文献
9.
A Usuba R Motoki Y Koizumi A Oishi Y Endo O Konno H Inoue 《Nihon Geka Gakkai zasshi》1990,91(8):931-941
Hypercoagulability develops after surgery for esophageal carcinoma, and it related closely to postoperative complications. This study evaluated the effects of the synthetic proteinase inhibitor, Cabexate Mesilate (FOY), on this hypercoagulability. The subjects used were 25 patients with a mean age of 63 who had undergone surgery for esophageal carcinoma. Of these, eight patients (test group) received FOY (2,000 mg/day) for three to 23 days after surgery, but 17 (control group) did not. In the test group, FOY controlled aggregation and release of the platelets and minimized their exhaustion. FOY almost completely checked the abnormal increase in thrombin activity which might trigger the hypercoagulability. Also, FOY suppressed the fibrinolytic activity slightly. These results indicate that FOY is effective in controlling hypercoagulability after surgery for esophageal carcinoma and in suppressing activity of the proteinases that cause both blood coagulation and fibrinolysis. 相似文献
10.
Yutaka Yonemura Masataka Segawa Hisashi Matsumoto Kouichirou Tsugawa Itasu Ninomiya Luis Fonseca Takashi Fujimura Kazuo Sugiyama Kouichi Miwa Itsuo Miyazaki 《Surgery today》1994,24(6):488-493
Because gastric cancers located in the upper third of the stomach are difficult to detect at an early stage, the surgical results remain poor. We performed R4 gastrectomy as a radical procedure for 25 patients, involving complete resection of the latero-aortic and interaorticovenous lymph modes above and below the left renal vein, in combination with the ordinary R2 or R3 gastrectomy (the R4 group). These patients were compared with 156 others who underwent R2 gastrectomy alone (the R2 group). There were no significant differences in operation time, blood loss, or the incidence of complications between the two groups; however, when the survival rates of the patients with tumors invading beyond the subserosa were compared, the 5-year survival rate was found to be significantly higher in the R4 group than in the R2 group. Furthermore, in patients with para-aortic nodal involvement, a significant survival advantage was observed in the R4 group, as compared with the R2 group. These results suggest that the R4 gastrectomy is a rational approach for patients with advanced gastric cancer located in the upper third of the stomach. 相似文献